Want to Partner with the Premier Exosome-Based Therapeutics Summit?
As exosome- and extracellular vesicle-based therapeutics continued to gain momentum across the precision, regenerative, and cell and gene therapy landscapes, the demand for specialized outsourcing services grew significantly in 2025.
The 7th Exosome-Based Therapeutic Development Summit served as the ultimate end-to-end platform for partnership and connection, bringing together a targeted audience of decision-makers and allowing companies to showcase their innovative solutions to a global audience of over 80 EV experts.
Unlike other events, the summit delivered an integrated approach that bridged the gap between laboratory discoveries and clinical and commercial application, solidifying its reputation as the premier platform for companies looking to lead and collaborate in the biotechnology sector
Audience Composition
Company Type
*Statistics taken from the 6th Exosome-Based Therapeutic Development Summit
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us at sponsor@hansonwade.com if you would like to get involved and discuss a bespoke package suited to your needs.